| Company Name: | Access Plans USA, Incorporated | | Ticker Symbol: | AUSA | | | WWW Address: | www.accessplansusa.com | | CEO: | Ian R Stuart | | No. of Employees: | 124 | | Common Issue Type: | CS | | Business Description: | The Company develops and distributes quality affordable consumer-driven healthcare programs for individuals, families, affinity groups and employer groups across the nation.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Business Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.2101 |  0.0 | 0.19 | 0.77 | 0 | 0.29 | 0.21 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4.3 | 20.3 | 0.51 | -0.69 | 0.00 | 0.0 | 0.0 | 1.08 - 0.12 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.21 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 4.3 | mil |
| Latest Shares Outstanding | 20.3 | mil |
| Earnings pS (EPS) | -0.69 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 321,952 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 13.4 | mil |
| Float as % of Shares Outstanding | 66.1 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | -3.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | -6.0 | % |
| EBITDA Margin | -2.9 | % |
| Pre-Tax Profit Margin | -4.2 | % |
| Assets Turnover | 2.0 | % |
| Return on Assets (ROA) | -9.7 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -18.2 | % |
| Current Ratio | 1.1 | |
| Leverage Ratio (Assets/Equity) | 2.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.15 | |
| LT Debt/Total Capital | 9.0 | % |
| Working Capital pS | 0.04 | $ |
| Cash pS | 0.06 | $ |
| Book-Value pS | 0.45 | $ |
| Tangible Book-Value pS | 0.03 | $ |
| Cash Flow pS | -0.04 | $ |
| Free Cash Flow pS | -0.11 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.47 | |
| Price/Tangible Book Ratio | 7.00 | |
| Price/Cash Flow | -5.3 | |
| Price/Free Cash Flow | -1.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -19.2 | 79 | 58 | 182 |
| 4 Weeks | 0.40 | 0.18 | 0.21 | 0.0 | 82 | 43 | 814 |
| 13 Weeks | 0.45 | 0.16 | 0.23 | -8.7 | 102 | 41 | 2,538 |
| 26 Weeks | 0.88 | 0.16 | 0.25 | -16.0 | 111 | 44 | 5,395 |
| 52 Weeks | 1.08 | 0.12 | 1.09 | -80.7 | 32 | 42 | 10,594 |
| YTD | 0.45 | 0.16 | - | -8.7 | 99 | 40 | 2,538 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.22 | 0.24 | 0.23 | 0.34 | 0.46 | 0.51 | 0.52 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -2.53 | 3.8 | 11.35 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 6.95 | NA | 35.42 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -6.1 | -15.3 | 81.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.62 | 0.34 | -0.11 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 5.17 |
| Current Ratio | 1.1 |
| Quick Ratio (Acid Test) | 0.5 |
| Liquidity Ratio (Cash) | 0.41 |
| Receivables Turnover | 48.8 |
| Average Collection Period | 7 |
| Working Capital/Equity | 9.6 |
| Working Capital pS | 0.05 |
| Cash-Flow pS | -0.59 |
| Free Cash-Flow pS | 0.03 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.80 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 45.9 |
| Total Debt/Equity (Gearing Ratio) | 0.12 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.2 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 2.07 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.93 |
| Tobin's Q Ratio | 0.20 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -9.31 |
| Enterprise Value (EV)/Free Cash Flow | 59.75 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 7.00 |
| Price/Book Ratio - LTM | 0.47 |
| Price/Cash Flow Ratio | -5.3 |
| Price/Free Cash Flow Ratio - LTM | -1.9 |
| Price/Sales Ratio | 0.11 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.47 |
| Tangible Book Value pS - LTM | 0.03 |
| Book Value pS - LTM | 0.45 |
| Capital Invested pS | 0.56 |
| Cash pS - LTM | 0.06 |
| Cash Flow pS - LTM | -0.04 |
| Free Cash Flow pS - LTM | -0.11 |
| Earnings pS (EPS) | -0.69 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 1.69 |
| Free Cash Flow Margin 5YEAR AVG | 3.19 |
| Net Profit Margin | -33.0 |
| Net Profit Margin - 5YEAR AVRG. | -18.6 |
| Equity Productivity | 3.61 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 3.61 |
| Return on Capital Invested (ROCI) | -116.9 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -28.8 |
| Assets Productivity | 2.10 |
| Return on Assets (ROA) | -63.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | -21.3 |
| Gross Profit Margin | -6.0 |
| Gross Profit Margin - 5YEAR AVRG. | 58.6 |
| EBITDA Margin - LTM | -2.9 |
| EBIT Margin - LTM | -3.4 |
| Pre-Tax Profit Margin | -34.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -17.7 |
| Effective Tax Rate | 4.3 |
| Effective Tax Rate - 5YEAR AVRG. | 13.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 10 |
| Revenue per Employee | 321,952 |
| Net Income per Employee | -106,089 |
| Average Collection Period | 10 |
| Receivables Turnover | 48.8 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 1673.8 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.38 |
| Assets/Revenue | 0.48 |
| Net Working Capital Turnover | 37.80 |
| Fixed Assets Turnover | 3.99 |
| Total Assets Turnover | 2.1 |
| Revenue per $ Cash | 14.73 |
| Revenue per $ Plant | 58.54 |
| Revenue per $ Common Equity | 3.55 |
| Revenue per $ Capital Invested | 3.55 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 31.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 60.3 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |